HZN-1116

· Amgen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HZN-1116, covering 2025-10-24 to 2025-10-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome [Phase 2]